Gilteritinib hemifumarate

Overview

Gilteritinib (ASP2215) hemifumarate is a potent and ATP-competitive FLT3 / AXL inhibitor with IC 50 of 0.29 nM/0.73 nM, respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer | Products > Signaling Pathways > FLT3 | Products > Signaling Pathways > TAM Receptor

Product Information

• Catalog No.: HY-12432A
• CAS No.: 1254053-84-3
• Molecular Formula: C29H44N8O30.5C4H4O4
• Molecular Weight: 610.75
• Purity: 99.75%
• Storage: 4°C, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
• Solubility: 0.5 mg/mL (0.82 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source